Lilly confirms date and conference call for third-quarter 2025 financial results announcement

Core Insights - Eli Lilly and Company will announce its third-quarter 2025 financial results on October 30, 2025, followed by a conference call for investors and media [1] - The company emphasizes its commitment to advancing healthcare through innovative treatments and clinical trials that reflect global diversity [1] Financial Results Announcement - The financial results will be disclosed on October 30, 2025, with a conference call starting at 10 a.m. Eastern time [1] - A live webcast of the conference call will be available on Lilly's website, with a replay accessible afterward [1] Company Overview - Eli Lilly has been a pioneer in medical discoveries for nearly 150 years, focusing on improving lives through biotechnology, chemistry, and genetic medicine [1] - The company addresses significant health challenges, including diabetes care, obesity treatment, Alzheimer's disease, immune system disorders, and difficult-to-treat cancers [1] - Lilly aims to ensure that its medicines are accessible and affordable while conducting innovative clinical trials [1]